Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 192791, 8 pages
http://dx.doi.org/10.1155/2012/192791
Research Article

HSV-1 miR-H6 Inhibits HSV-1 Replication and IL-6 Expression in Human Corneal Epithelial Cells In Vitro

1Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, 54 Xianlie Road, Guangzhou 510060, China
2Department of Ophthalmology, Renmin Hospital, Wuhan University, Wuhan 430060, China

Received 18 December 2011; Accepted 1 February 2012

Academic Editor: Lbachir BenMohamed

Copyright © 2012 Fang Duan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Taylor, M. A. Brockman, E. E. McNamee, and D. M. Knipe, “Herpes simplex virus,” Front Biosci, vol. 7, pp. 752–764, 2002. View at Google Scholar · View at Scopus
  2. H. S. Toma, A. T. Murina, R. G. Areaux et al., “Ocular HSV-1 latency, reactivation and recurrent disease,” Seminars in Ophthalmology, vol. 23, no. 4, pp. 249–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Mador, D. Goldenberg, O. Cohen, A. Panet, and I. Steiner, “Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line,” Journal of Virology, vol. 72, no. 6, pp. 5067–5075, 1998. View at Google Scholar · View at Scopus
  4. J. L. Umbach, M. F. Kramer, I. Jurak, H. W. Karnowski, D. M. Coen, and B. R. Cullen, “MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs,” Nature, vol. 454, no. 7205, pp. 780–783, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Duan, S. Ni, Y. Nie, Q. Huang, and K. Wu, “SiRNA targeting for ICP4 inhibits HSV-1 replication in retinal pigment epithelial cells,” Clinical and Experimental Ophthalmology, vol. 40, no. 2, pp. 195–204, 2012. View at Publisher · View at Google Scholar
  6. C. Clusel, S. Meguenni, I. Elias, M. Vasseur, and M. Blumenfeld, “Inhibition of HSV-1 proliferation by decoy phosphodiester oligonucleotides containing ICP4 recognition sequences,” Gene Expression, vol. 4, no. 6, pp. 301–309, 1995. View at Google Scholar · View at Scopus
  7. Y. T. Liu, B. Song, Y. L. Wang et al., “SiRNA targeting ICP4 attenuates HSV-1 replication,” Bing Du Xue Bao, vol. 26, no. 3, pp. 163–169, 2010. View at Google Scholar · View at Scopus
  8. C. Y. Lee, P. S. Rennie, and W. W. Jia, “MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells,” Clinical Cancer Research, vol. 15, no. 16, pp. 5126–5135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Pfeffer, M. Zavolan, F. A. Grässer et al., “Identification of virus-encoded microRNAs,” Science, vol. 304, no. 5671, pp. 734–736, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. S. Sullivan and D. Ganem, “MicroRNAs and viral infection,” Molecular Cell, vol. 20, no. 1, pp. 3–7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Takane and A. Kanai, “Vertebrate virus-encoded microRNAs and their sequence conservation,” Japanese Journal of Infectious Diseases, vol. 64, no. 5, pp. 357–366, 2011. View at Google Scholar
  13. I. W. Boss and R. Renne, “Viral miRNAs: tools for immune evasion,” Current Opinion in Microbiology, vol. 13, no. 4, pp. 540–545, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Cui, A. Griffiths, G. Li et al., “Prediction and identification of herpes simplex virus 1-encoded microRNAs,” Journal of Virology, vol. 80, no. 11, pp. 5499–5508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Hill, Y. Zhao, C. Clement, D. M. Neumann, and W. J. Lukiw, “HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling,” NeuroReport, vol. 20, no. 16, pp. 1500–1505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Jurak, M. F. Kramer, J. C. Mellor et al., “Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2,” Journal of Virology, vol. 84, no. 9, pp. 4659–4672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. F. Kramer, I. Jurak, J. M. Pesola, S. Boissel, D. M. Knipe, and D. M. Coen, “Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia,” Virology, vol. 417, no. 2, pp. 239–247, 2011. View at Publisher · View at Google Scholar
  18. S. Tang, A. S. Bertke, A. Patel, T. P. Margolis, and P. R. Krause, “Herpes simplex virus 2 MicroRNA miR-H6 is a novel latency-associated transcript-associated MicroRNA, but reduction of its expression does not influence the establishment of viral latency or the recurrence phenotype,” Journal of Virology, vol. 85, no. 9, pp. 4501–4509, 2011. View at Publisher · View at Google Scholar
  19. B. Roizman and R. J. Whitley, “The nine ages of herpes simplex virus,” Herpes, vol. 8, no. 1, pp. 23–27, 2001. View at Google Scholar · View at Scopus
  20. R. J. Whitley and F. Lakeman, “Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations,” Clinical Infectious Diseases, vol. 20, no. 2, pp. 414–420, 1995. View at Google Scholar · View at Scopus
  21. L. Remeijer, R. Duan, J. M. van Dun, M. A. W. Bettink, A. D. Osterhaus, and G. M. Verjans, “Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues,” Journal of Infectious Diseases, vol. 200, no. 1, pp. 11–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. P. Kennedy, C. Clement, R. L. Arceneaux, P. S. Bhattacharjee, T. S. Huq, and J. M. Hill, “Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?” Cornea, vol. 30, no. 3, pp. 251–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Divito and R. L. Hendricks, “Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1488–1495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. R. Mott, C. J. Bresee, S. J. Allen, L. BenMohamed, S. L. Wechsler, and H. Ghiasi, “Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice,” Journal of Virology, vol. 83, no. 5, pp. 2246–2254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. T. H. Stumpf, R. Case, C. Shimeld, D. L. Easty, and T. J. Hill, “Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids,” Journal of General Virology, vol. 83, no. 7, pp. 1579–1590, 2002. View at Google Scholar · View at Scopus
  26. D. M. Koelle, S. N. Reymond, H. Chen et al., “Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans,” Journal of Virology, vol. 74, no. 23, pp. 10930–10938, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. P. C. Heinrich, I. Behrmann, G. Muller-Newen, F. Schaper, and L. Graeve, “Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway,” Biochemical Journal, vol. 334, no. 2, pp. 297–314, 1998. View at Google Scholar · View at Scopus
  28. J. D. Kriesel, J. Ricigliano, S. L. Spruance, H. H. Garza Jr., and J. M. Hill, “Neuronal reactivation of herpes simplex virus may involve interleukin-6,” Journal of NeuroVirology, vol. 3, no. 6, pp. 441–448, 1997. View at Google Scholar · View at Scopus
  29. S. R. Paludan, “Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes,” Journal of Virology, vol. 75, no. 17, pp. 8008–8015, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Kanangat, J. S. Babu, D. M. Knipe, and B. T. Rouse, “HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression,” Virology, vol. 219, no. 1, pp. 295–300, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Donnarumma, V. De Gregorio, A. Fusco et al., “Inhibition of HSV-1 replication by laser diode-irradiation: possible mechanism of action,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 4, pp. 1167–1176, 2010. View at Google Scholar
  32. K. Hayashi, L. C. Hooper, M. S. Chin, C. N. Nagineni, B. Detrick, and J. J. Hooks, “Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors,” Journal of General Virology, vol. 87, no. 8, pp. 2161–2169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. liu, G. Song, Z. Wang et al., “Establishment of a corneal epithelial cell line spontaneously derived from human limbal cells,” Experimental Eye Research, vol. 84, no. 3, pp. 599–609, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Nie, D. Cui, Z. Pan, J. Deng, Q. Huang, and K. Wu, “HSV-1 infection suppresses TGF-β1 and SMAD3 expression in human corneal epithelial cells,” Molecular Vision, vol. 14, pp. 1631–1638, 2008. View at Google Scholar · View at Scopus
  35. W. K. Baumgaertner, A. E. Metzler, S. Krakowa, and A. Koestner, “In vitro identification and characterization of a virus isolated from a dog with neurological dysfunction,” Infection and Immunity, vol. 31, no. 3, pp. 1177–1183, 1981. View at Google Scholar · View at Scopus
  36. N. A. DeLuca and P. A. Schaffer, “Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4,” Molecular and Cellular Biology, vol. 5, no. 8, pp. 1997–2008, 1985. View at Google Scholar · View at Scopus
  37. C. A. Smith, P. Bates, R. Rivera-Gonzalez, B. Gu, and N. A. DeLuca, “ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB,” Journal of Virology, vol. 67, no. 8, pp. 4676–4687, 1993. View at Google Scholar · View at Scopus
  38. L. J. Al-Dujaili, P. P. Clerkin, C. Clement et al., “Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?” Future Microbiology, vol. 6, no. 8, pp. 877–907, 2011. View at Google Scholar
  39. J. L. Umbach, M. A. Nagel, R. J. Cohrs, D. H. Gilden, and B. R. Cullen, “Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia,” Journal of Virology, vol. 83, no. 20, pp. 10677–10683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Du, G. Zhou, and B. Roizman, “HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 46, pp. 18820–18824, 2011. View at Publisher · View at Google Scholar
  41. R. S. Jawa, S. Anillo, K. Huntoon, H. Baumann, and M. Kulaylat, “Analytic review: interleukin-6 in surgery, trauma, and critical care: part I: basic science,” Journal of Intensive Care Medicine, vol. 26, no. 1, pp. 3–12, 2011. View at Publisher · View at Google Scholar
  42. T. Hirano, “Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir,” Proceedings of the Japan Academy Series B, vol. 86, no. 7, pp. 717–730, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Li, J. Zhang, A. Kumar, M. Zheng, S. S. Atherton, and F. S. X. Yu, “Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells,” Immunology, vol. 117, no. 2, pp. 167–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. J. D. Kriesel, B. M. Gebhardt, J. M. Hill et al., “Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation,” Journal of Infectious Diseases, vol. 175, no. 4, pp. 821–827, 1997. View at Google Scholar · View at Scopus
  45. V. Arrunategui-Correa, S. Baltatzis, and C. S. Foster, “The role of cytokines in experimental herpes simplex keratitis,” Acta Virologica, vol. 43, no. 5, pp. 325–329, 1999. View at Google Scholar · View at Scopus
  46. P. S. Biswas, K. Banerjee, P. R. Kinchington, and B. T. Rouse, “Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection,” Experimental Eye Research, vol. 82, no. 1, pp. 46–54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. R. B. Tunnicliffe, G. M. Hautbergue, P. Kalra et al., “Structural basis for the recognition of cellular mRNA export factor REF by herpes viral proteins HSV-1 ICP27 and HVS ORF57,” Plos Pathogens, vol. 7, no. 1, Article ID e1001244, 2011. View at Publisher · View at Google Scholar
  48. J. G. Kang, N. Pripuzova, V. Majerciak, M. Kruhlak, S.-Y. Le, and Z. M. Zheng, “Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression,” Journal of Virology, vol. 85, no. 6, pp. 2620–2630, 2011. View at Publisher · View at Google Scholar